Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Transfer Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111793017A details a safe ruthenium-catalyzed transfer hydrogenation method for high-ee lactams, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN113999084A details a novel asymmetric synthesis of (S)-nicotine via myosmine reduction, offering high purity and cost-effective manufacturing for reliable suppliers.
Patent CN109096329B details a novel asymmetric transfer hydrogenation for chiral beta-hydroxy phosphates, offering cost-effective routes for pharmaceutical intermediates.
Patent CN113999201A details a novel asymmetric synthesis of S-nicotine, offering high purity and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Patent CN112675920B reveals a novel monochiral ruthenium catalyst enabling efficient asymmetric hydrogenation and kinetic resolution for high-purity pharmaceutical intermediates.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.